APR-2016 : Best Patient-Focused Technological Development at the First Clinical and Research Excellence Awards event, 27 April in Boston.
AARDEX platform winner of the Best Patient-Focused Technological Development
APR-2016 : Best Patient-Focused Technological Development at the First Clinical and Research Excellence Awards event, 27 April in Boston.
AARDEX platform winner of the Best Patient-Focused Technological Development
Liège, Belgium and Gothenburg, Sweden – October 15, 2024: AARDEX Group, a leader in managing drug exposure in clinical trials, and precision medicine innovators, and OnDosis, a game changer in precision dosing of oral solid medicines through the novel Dosage
In recent years, the pharmaceutical industry has borne witness to the meteoric rise of glucagon-like peptide-1 receptor agonist (GLP-1) therapies. Having fast become established as a potentially life-changing treatment for Type 2 diabetes and obesity, emerging evidence of the cardio and